| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Recursion Pharmaceuticals has a consensus price target of $7.81.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $3.545 last updated October 22, 2026 at 3:44 PM EDT.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
